TipRanks
pc:prece

Precede Biosciences

Boston, MA, US
https://www.precede.bio/
Precede Biosciences is a precision diagnostics and data company focused on enabling the next generation of precision medicines, with an initial emphasis on cancer. The company develops a blood-based platform that integrates a single, automated assay with machine learning to extract genome-wide transcriptional and epigenomic signals for use in drug development and clinical decision-making.

Leadership & Board

Current Number of Employees68
Current LinkedIn Followers6,829

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$84M
Total Amount Raised$84M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$84M
Latest Funding Amount$84M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―

Employee Trend

Precede Biosciences had 68 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
68Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Precede Biosciences had 6,829 followers as of September 28, 2026. The number of followers increased by 12 (0.18%) week-over-week.
6,829Latest Followers Count
12(0.18%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 12, 2026
Series B
$83.50M
―

Investors

Similar Companies

A snapshot of private companies similar to Precede Biosciences, helping you discover and navigate related company profiles.

Related News and Analysis